National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Amstutz A, Schandelmaier S, Ewald H, Speich B, Schwenke JM, Schönenberger CM, Schobinger S, Agoritsas T, Tomashek KM, Nayak S, Makowski M, Morales-Ortega A, Bernal-Bello D, Pomponio G, Ferrarini A, Ghazaeian M, Hall F, Bond S, García-Morales MT, Jiménez-González M, Arribas JR, Guimaraães PO, Tavares CAM, Berwanger O, Yazdanpanah Yet al.(2025) Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials Lancet Respir Med(in press) DOI 10.1016/S2213-2600(25)00055-4, PubMed 40378861
Miller A, Symington F, Garner P, Pedersen M(2025) Patients with severe ME/CFS need hope and expert multidisciplinary care BMJ, 389, r977 DOI 10.1136/bmj.r977, PubMed 40368436